Origin Bancorp, Inc. (NASDAQ:OBK) Receives Consensus Rating of “Moderate Buy” from Brokerages
Shares of Origin Bancorp, Inc. (NASDAQ:OBK – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the five research firms that are presently covering the stock, MarketBeat.com reports. One research analyst has rated the stock with a hold rating and four have issued a buy rating on the company. The average […]
Brokerages Set Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) PT at $35.89
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the nine brokerages that are covering the firm, MarketBeat.com reports. One analyst has rated the stock with a hold rating and eight have assigned a buy rating to the company. The average 1 year target price among brokerages […]
Solid Biosciences Inc. (NASDAQ:SLDB) Receives Average Rating of “Buy” from Brokerages
Shares of Solid Biosciences Inc. (NASDAQ:SLDB – Get Free Report) have been assigned an average rating of “Buy” from the eight brokerages that are covering the stock, MarketBeat.com reports. Six research analysts have rated the stock with a buy recommendation and two have assigned a strong buy recommendation to the company. The average 1-year target […]
CCC Intelligent Solutions Holdings Inc. (NYSE:CCCS) Receives Average Rating of “Moderate Buy” from Analysts
Shares of CCC Intelligent Solutions Holdings Inc. (NYSE:CCCS – Get Free Report) have been assigned an average rating of “Moderate Buy” from the eight brokerages that are currently covering the stock, MarketBeat reports. Three research analysts have rated the stock with a hold recommendation and five have given a buy recommendation to the company. The […]
Carter’s, Inc. (NYSE:CRI) Receives $71.17 Consensus PT from Analysts
Carter’s, Inc. (NYSE:CRI – Get Free Report) has received an average recommendation of “Reduce” from the seven brokerages that are currently covering the company, MarketBeat reports. Two equities research analysts have rated the stock with a sell recommendation and five have given a hold recommendation to the company. The average 12 month target price among […]
Bruker Co. (NASDAQ:BRKR) Receives Consensus Rating of “Moderate Buy” from Analysts
Shares of Bruker Co. (NASDAQ:BRKR – Get Free Report) have received a consensus rating of “Moderate Buy” from the eleven analysts that are presently covering the company, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, three have given a hold recommendation and seven have assigned a buy recommendation […]
Penumbra, Inc. (NYSE:PEN) Receives Average Rating of “Moderate Buy” from Analysts
Shares of Penumbra, Inc. (NYSE:PEN – Get Free Report) have been given an average rating of “Moderate Buy” by the fourteen analysts that are currently covering the stock, Marketbeat Ratings reports. Five research analysts have rated the stock with a hold recommendation, eight have assigned a buy recommendation and one has issued a strong buy […]
IDEX Co. (NYSE:IEX) Receives Average Recommendation of “Moderate Buy” from Analysts
IDEX Co. (NYSE:IEX – Get Free Report) has been given an average rating of “Moderate Buy” by the eight ratings firms that are covering the firm, Marketbeat Ratings reports. Two research analysts have rated the stock with a hold recommendation and six have given a buy recommendation to the company. The average 12-month price target […]
Advance Auto Parts, Inc. (NYSE:AAP) Receives $56.54 Average Target Price from Analysts
Advance Auto Parts, Inc. (NYSE:AAP – Get Free Report) has received a consensus rating of “Hold” from the sixteen brokerages that are covering the firm, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, fourteen have assigned a hold rating and one has assigned a buy rating to the company. […]
Boston Scientific (NYSE:BSX) PT Raised to $100.00
Boston Scientific (NYSE:BSX – Get Free Report) had its price objective upped by Stifel Nicolaus from $85.00 to $100.00 in a report issued on Friday, Benzinga reports. The brokerage currently has a “buy” rating on the medical equipment provider’s stock. Stifel Nicolaus’ target price points to a potential upside of 14.17% from the stock’s current […]
Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Given Average Recommendation of “Moderate Buy” by Brokerages
Acadia Healthcare Company, Inc. (NASDAQ:ACHC – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the ten research firms that are currently covering the company, Marketbeat.com reports. Four equities research analysts have rated the stock with a hold rating and six have issued a buy rating on the company. The average […]
Amkor Technology, Inc. (NASDAQ:AMKR) Receives Consensus Rating of “Moderate Buy” from Brokerages
Shares of Amkor Technology, Inc. (NASDAQ:AMKR – Get Free Report) have earned an average recommendation of “Moderate Buy” from the nine analysts that are presently covering the stock, Marketbeat reports. Three analysts have rated the stock with a hold recommendation, five have given a buy recommendation and one has assigned a strong buy recommendation to […]
Utz Brands, Inc. (NYSE:UTZ) Receives Average Rating of “Moderate Buy” from Brokerages
Shares of Utz Brands, Inc. (NYSE:UTZ – Get Free Report) have received an average recommendation of “Moderate Buy” from the eleven ratings firms that are covering the stock, Marketbeat Ratings reports. Three investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. The average 1 […]
Enovix Co. (NASDAQ:ENVX) Receives Average Recommendation of “Buy” from Brokerages
Shares of Enovix Co. (NASDAQ:ENVX – Get Free Report) have been given a consensus recommendation of “Buy” by the ten research firms that are covering the stock, Marketbeat reports. One research analyst has rated the stock with a hold recommendation, eight have assigned a buy recommendation and one has given a strong buy recommendation to […]
Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Receives Consensus Recommendation of “Buy” from Brokerages
Shares of Zevra Therapeutics, Inc. (NASDAQ:ZVRA – Get Free Report) have been assigned a consensus recommendation of “Buy” from the eight research firms that are covering the company, Marketbeat Ratings reports. Seven research analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company. The average […]
last updated on 19 Oct 11:30